Consolidated Balance Sheets - USD ($)	Jun. 30, 2025	Jun. 30, 2024
CURRENT ASSETS
Cash and cash equivalents	$ 68,108	$ 115,747
Accounts receivable		184,692
Total current assets	68,108	300,439
TOTAL ASSETS	68,108	300,439
CURRENT LIABILITIES
Accounts payable	19,410	90,785
Accrued interest	104,877	85,650
Accrued executive compensation	17,000	58,333
Notes payable-third parties	300,000	435,000
Loans payable, related party	100	68,269
Derivative liability (as restated at June 30, 2024 – See Note N)	780,000	498,000
Total current liabilities	1,221,387	1,236,037
TOTAL LIABILITIES	1,221,387	1,236,037
STOCKHOLDERS’ EQUITY (DEFICIENCY):
Additional paid- in capital Class A common stock	162,898,727	162,898,727
Additional paid- in capital preferred stock	2,014,892	1,861,142
Common stock to be issued		30,000
Accumulated deficit (as restated at June 30, 2024 – See Note N)	(167,555,637)	(167,212,956)
Total stockholders’ equity (deficiency)	(1,153,279)	(935,598)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIENCY)	68,108	300,439
Series K Preferred Stock [Member]
STOCKHOLDERS’ EQUITY (DEFICIENCY):
Preferred stock value
Series L Preferred Stock [Member]
STOCKHOLDERS’ EQUITY (DEFICIENCY):
Preferred stock value
Series N Preferred Stock [Member]
STOCKHOLDERS’ EQUITY (DEFICIENCY):
Preferred stock value	19,895	18,645
Common Class A [Member]
STOCKHOLDERS’ EQUITY (DEFICIENCY):
Class A Common stock; 14,991,000,000 shares authorized, $.0001 par value, as of June 30, 2025 and 2024, there are 14,688,440,097 shares issued and outstanding, respectively	$ 1,468,844	$ 1,468,844